Endurant Evo US Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 139 participants.
Also called NCT02393716
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 139 participants
- Sponsor
- Registry
-
NCT02393716
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT02393716. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2021-06-25 (actual). Results posted on 2022-12-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endurant Evo US Clinical Trial
- Condition
- Abdominal Aortic Aneurysm
- Condition
- AAA
- Intervention (Device)
- Endurant Evo AAA Stent Graft System
- Intervention (Procedure)
- Endovascular aneurysm repair (EVAR)
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct02393716- Content hash
cdaaf2d8d140a8a86631762b66ce6639c790fc9161b49e6979ee09a81aeecaf9